Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by BencrosMumon Feb 11, 2021 3:02pm
221 Views
Post# 32543199

RE:RE:what was I thinking ?

RE:RE:what was I thinking ?

Wow!! 7 of 270 patients saw their tumour disappear completely 
going to be hard to beat those numbers 




Pandora wrote:
BNN Marketcall has a "LargeCap" Health portfolio guy on this morning i.e. he doesn't really deal with anything below $100.

On another subject he made a passing remark about Opdivo making good progress on a baldder cancer trial but did not go any further with that.

https://www.opdivo.com/advanced-bladder-cancer

His 3 top picks were between $100 and $300 and his closing comment was words to the effect that the Biden admin should be positive for the health sector.

 

<< Previous
Bullboard Posts
Next >>